Andrew P. Levy

13.0k total citations · 4 hit papers
179 papers, 9.9k citations indexed

About

Andrew P. Levy is a scholar working on Cell Biology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Andrew P. Levy has authored 179 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cell Biology, 52 papers in Molecular Biology and 39 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Andrew P. Levy's work include Hemoglobin structure and function (96 papers), Neonatal Health and Biochemistry (33 papers) and Pancreatic function and diabetes (28 papers). Andrew P. Levy is often cited by papers focused on Hemoglobin structure and function (96 papers), Neonatal Health and Biochemistry (33 papers) and Pancreatic function and diabetes (28 papers). Andrew P. Levy collaborates with scholars based in Israel, United States and Canada. Andrew P. Levy's co-authors include Nina S. Levy, Mark A. Goldberg, Scott A. Wegner, Rabea Asleh, Rachel Miller‐Lotan, Henry Furneaux, William G. Kaelin, Othon Iliopoulos, Cong Jiang and Pedro Moreno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Andrew P. Levy

173 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia

1995 909 citations Andrew P. Levy, Nina S. Levy et al. profile →
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

1996 713 citations Othon Iliopoulos, Andrew P. Levy et al. profile →
Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR

1998 547 citations Nina S. Levy, Andrew P. Levy et al. profile →
Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia

1996 524 citations Andrew P. Levy, Nina S. Levy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew P. Levy Israel	50	4.6k	2.6k	2.5k	1.5k	1.4k	179	9.9k
Christian Bauer Germany	47	3.0k 0.7×	1.1k 0.4×	2.3k 0.9×	2.5k 1.6×	676 0.5×	166	8.7k
Ian Zachary United Kingdom	59	7.6k 1.7×	1.6k 0.6×	1.6k 0.7×	667 0.4×	944 0.7×	138	11.3k
Sten Eirik W. Jacobsen Sweden	77	8.8k 1.9×	1.2k 0.5×	1.4k 0.6×	1.3k 0.9×	1.8k 1.2×	312	21.6k
Zoltàn Arany United States	61	9.0k 2.0×	1.4k 0.5×	3.1k 1.3×	4.7k 3.0×	1.7k 1.2×	174	16.1k
Takao Hamakubo Japan	57	6.6k 1.5×	1.1k 0.4×	1.3k 0.5×	965 0.6×	1.1k 0.8×	237	10.7k
Yasushi Fujio Japan	49	5.9k 1.3×	1.2k 0.4×	1.0k 0.4×	2.2k 1.4×	1.5k 1.0×	180	11.6k
Tobias B. Huber Germany	56	5.7k 1.3×	1.1k 0.4×	634 0.3×	1.0k 0.7×	1.4k 1.0×	257	12.7k
Juro Sakai Japan	50	5.2k 1.1×	1.1k 0.4×	1.5k 0.6×	1.6k 1.0×	2.4k 1.7×	107	8.5k
Toshiyuki Takeuchi Japan	46	3.9k 0.9×	1.5k 0.6×	1.2k 0.5×	575 0.4×	2.2k 1.5×	178	8.3k
Samuel E. Lux United States	53	3.5k 0.8×	1.4k 0.5×	635 0.3×	3.9k 2.5×	1.4k 1.0×	114	9.4k

Countries citing papers authored by Andrew P. Levy

Since Specialization

Citations

This map shows the geographic impact of Andrew P. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Levy more than expected).

Fields of papers citing papers by Andrew P. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Levy. The network helps show where Andrew P. Levy may publish in the future.

Co-authorship network of co-authors of Andrew P. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. Levy. A scholar is included among the top collaborators of Andrew P. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. Levy. Andrew P. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bancks, Michael P., Mark A. Espeland, Judy Bahnson, et al.. (2024). The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study. Cardiovascular Diabetology. 23(1). 356–356. 2 indexed citations

Levy, Nina S., Shlomo Wagner, Shai Netser, et al.. (2023). Daily Brief Heat Therapy Reduces Seizures in A350V IQSEC2 Mice and Is Associated with Correction of AMPA Receptor-Mediated Synaptic Dysfunction. International Journal of Molecular Sciences. 24(4). 3924–3924. 2 indexed citations

Andreou, Pantelis, Andrew P. Levy, John L. Sapp, et al.. (2023). Relationship Between Time‐Varying Achieved High‐Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study. Journal of the American Heart Association. 12(19). e030288–e030288. 3 indexed citations

Bergmann, Eyal, Alexandra Kavushansky, Nadav Cohen, et al.. (2021). Structural and functional brain-wide alterations in A350V Iqsec2 mutant mice displaying autistic-like behavior. Translational Psychiatry. 11(1). 181–181. 7 indexed citations

Berinstein, Elliot & Andrew P. Levy. (2017). Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments. Expert Opinion on Drug Metabolism & Toxicology. 13(9). 973–983. 18 indexed citations

Levine, Rachel B., et al.. (2017). Evaluation of a course to prepare international students for the United States Medical Licensing Examination step 2 clinical skills exam. Journal of Educational Evaluation for Health Professions. 14. 25–25. 4 indexed citations

Cahill, Leah E., Majken K. Jensen, Stephanie E. Chiuve, et al.. (2015). The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype. Journal of the American College of Cardiology. 66(16). 1791–1799. 42 indexed citations

Cahill, Leah E., Andrew P. Levy, Stephanie E. Chiuve, et al.. (2013). Haptoglobin Genotype Is a Consistent Marker of Coronary Heart Disease Risk Among Individuals With Elevated Glycosylated Hemoglobin. Journal of the American College of Cardiology. 61(7). 728–737. 71 indexed citations

Asaf, Roy, Shany Blum, Ariel Roguin, et al.. (2009). Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice. Cardiovascular Diabetology. 8(1). 29–29. 13 indexed citations

10.

Blum, Shany, Roy Asaf, Julia Guetta, et al.. (2006). Haptoglobin Genotype Determines Myocardial Infarct Size in Diabetic Mice. Journal of the American College of Cardiology. 49(1). 82–87. 50 indexed citations

11.

Levy, Andrew P., Lin Zhang, Rachel Miller‐Lotan, et al.. (2005). Haptoglobin Phenotype, Sleep-Disordered Breathing, and the Prevalence of Cardiovascular Disease: the Sleep Heart Health Study. SLEEP. 28(2). 207–214. 6 indexed citations

12.

Lejbkowicz, Flavio, et al.. (2005). New horizons for VEGF. Is there a role for nuclear localization?. Acta Histochemica. 106(6). 405–411. 33 indexed citations

13.

Levy, Andrew P., Martin G. Larson, Diane Corey, et al.. (2003). Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort. Atherosclerosis. 172(2). 361–365. 48 indexed citations

14.

Beiran, Itzchak, et al.. (2003). Haptoglobin phenotype in age-related macular degeneration patients. American Journal of Ophthalmology. 136(5). 911–914. 1 indexed citations

15.

Levy, Andrew P., Irit Hochberg, Kathleen Jablonski, et al.. (2002). Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes. Journal of the American College of Cardiology. 40(11). 1984–1990. 224 indexed citations

16.

Patel, Sanjay R., Jeffrey A. Breall, Daniel J. Diver, Bernard J. Gersh, & Andrew P. Levy. (2000). Bradycardia is associated with development of coronary collateral vessels in humans. Coronary Artery Disease. 11(6). 467–472. 31 indexed citations

17.

Avivi, Aaron, et al.. (1999). Adaptive hypoxic tolerance in the subterranean mole rat Spalax ehrenbergi: the role of vascular endothelial growth factor. FEBS Letters. 452(3). 133–140. 75 indexed citations

18.

Levy, Andrew P.. (1998). Hypoxic Regulation of VEGF mRNA Stability by RNA-binding Proteins. Trends in Cardiovascular Medicine. 8(6). 246–250. 51 indexed citations

19.

Levy, Andrew P., et al.. (1997). Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney International. 51(2). 575–578. 66 indexed citations

20.

Levy, Andrew P., et al.. (1989). An Endothelial Cell Growth Factor from the Mouse Neuroblastoma Cell Line NB41. Growth Factors. 2(1). 9–19. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact